BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30597051)

  • 1. Myostatin Inhibition Using ActRIIB-mFc Does Not Produce Weight Gain or Strength in the Nebulin Conditional KO Mouse.
    Tinklenberg JA; Siebers EM; Beatka MJ; Fickau BA; Ayres S; Meng H; Yang L; Simpson P; Granzier HL; Lawlor MW
    J Neuropathol Exp Neurol; 2019 Feb; 78(2):130-139. PubMed ID: 30597051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.
    Tinklenberg J; Meng H; Yang L; Liu F; Hoffmann RG; Dasgupta M; Allen KP; Beggs AH; Hardeman EC; Pearsall RS; Fitts RH; Lawlor MW
    Am J Pathol; 2016 Jun; 186(6):1568-81. PubMed ID: 27102768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
    Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
    Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulin deficiency in adult muscle causes sarcomere defects and muscle-type-dependent changes in trophicity: novel insights in nemaline myopathy.
    Li F; Buck D; De Winter J; Kolb J; Meng H; Birch C; Slater R; Escobar YN; Smith JE; Yang L; Konhilas J; Lawlor MW; Ottenheijm C; Granzier HL
    Hum Mol Genet; 2015 Sep; 24(18):5219-33. PubMed ID: 26123491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.
    Lawlor MW; Read BP; Edelstein R; Yang N; Pierson CR; Stein MJ; Wermer-Colan A; Buj-Bello A; Lachey JL; Seehra JS; Beggs AH
    Am J Pathol; 2011 Feb; 178(2):784-93. PubMed ID: 21281811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Inhibition of Myostatin in a Mouse Model of Typical Nemaline Myopathy Increases Muscle Size and Force.
    Lindqvist J; Granzier H
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice.
    Tinklenberg JA; Siebers EM; Beatka MJ; Meng H; Yang L; Zhang Z; Ross JA; Ochala J; Morris C; Owens JM; Laing NG; Nowak KJ; Lawlor MW
    Hum Mol Genet; 2018 Feb; 27(4):638-648. PubMed ID: 29293963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency.
    Ottenheijm CA; Witt CC; Stienen GJ; Labeit S; Beggs AH; Granzier H
    Hum Mol Genet; 2009 Jul; 18(13):2359-69. PubMed ID: 19346529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressing a Z-disk nebulin fragment in nebulin-deficient mouse muscle: effects on muscle structure and function.
    Li F; Kolb J; Crudele J; Tonino P; Hourani Z; Smith JE; Chamberlain JS; Granzier H
    Skelet Muscle; 2020 Jan; 10(1):2. PubMed ID: 31992366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.
    Rahimov F; King OD; Warsing LC; Powell RE; Emerson CP; Kunkel LM; Wagner KR
    Physiol Genomics; 2011 Apr; 43(8):398-407. PubMed ID: 21266502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
    Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omecamtiv mecarbil lowers the contractile deficit in a mouse model of nebulin-based nemaline myopathy.
    Lindqvist J; Lee EJ; Karimi E; Kolb J; Granzier H
    PLoS One; 2019; 14(11):e0224467. PubMed ID: 31721788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast skeletal muscle troponin activation increases force of mouse fast skeletal muscle and ameliorates weakness due to nebulin-deficiency.
    Lee EJ; De Winter JM; Buck D; Jasper JR; Malik FI; Labeit S; Ottenheijm CA; Granzier H
    PLoS One; 2013; 8(2):e55861. PubMed ID: 23437068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
    Chiu CS; Peekhaus N; Weber H; Adamski S; Murray EM; Zhang HZ; Zhao JZ; Ernst R; Lineberger J; Huang L; Hampton R; Arnold BA; Vitelli S; Hamuro L; Wang WR; Wei N; Dillon GM; Miao J; Alves SE; Glantschnig H; Wang F; Wilkinson HA
    J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1181-92. PubMed ID: 23525481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function.
    Sztal TE; Zhao M; Williams C; Oorschot V; Parslow AC; Giousoh A; Yuen M; Hall TE; Costin A; Ramm G; Bird PI; Busch-Nentwich EM; Stemple DL; Currie PD; Cooper ST; Laing NG; Nowak KJ; Bryson-Richardson RJ
    Acta Neuropathol; 2015 Sep; 130(3):389-406. PubMed ID: 25931053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.
    Bondulich MK; Jolinon N; Osborne GF; Smith EJ; Rattray I; Neueder A; Sathasivam K; Ahmed M; Ali N; Benjamin AC; Chang X; Dick JRT; Ellis M; Franklin SA; Goodwin D; Inuabasi L; Lazell H; Lehar A; Richard-Londt A; Rosinski J; Smith DL; Wood T; Tabrizi SJ; Brandner S; Greensmith L; Howland D; Munoz-Sanjuan I; Lee SJ; Bates GP
    Sci Rep; 2017 Oct; 7(1):14275. PubMed ID: 29079832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
    Liu M; Hammers DW; Barton ER; Sweeney HL
    PLoS One; 2016; 11(11):e0166803. PubMed ID: 27870893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition.
    Goncalves MD; Pistilli EE; Balduzzi A; Birnbaum MJ; Lachey J; Khurana TS; Ahima RS
    PLoS One; 2010 Sep; 5(9):e12707. PubMed ID: 20856813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Characterization of the Intact Diaphragm in a Nebulin-Based Nemaline Myopathy (NM) Model-Effects of the Fast Skeletal Muscle Troponin Activator
    Lee EJ; Kolb J; Hwee DT; Malik FI; Granzier HL
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo characterization of skeletal muscle function in nebulin-deficient mice.
    Gineste C; Ogier AC; Varlet I; Hourani Z; Bernard M; Granzier H; Bendahan D; Gondin J
    Muscle Nerve; 2020 Mar; 61(3):416-424. PubMed ID: 31893464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.